Rivastigmine - NDC Database (Page 5)
63629-8846 Dec 19, 2019
Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
63739-576 Mar 01, 2013
Rivastigmine 1.5 mg (As Rivastigmine Tartrate 2.4 mg) Oral Capsule by Mckesson Packaging Services a Business Unit of Mckesson Corporation
Rivastigmine 1.5 mg (As Rivastigmine Tartrate 2.4 mg) Oral Capsule by Mckesson Packaging Services a Business Unit of Mckesson Corporation
63739-577 Feb 01, 2013
Rivastigmine 3 mg (As Rivastigmine Tartrate 4.8 mg) Oral Capsule by Mckesson Packaging Services a Business Unit of Mckesson Corporation
Rivastigmine 3 mg (As Rivastigmine Tartrate 4.8 mg) Oral Capsule by Mckesson Packaging Services a Business Unit of Mckesson Corporation
70710-1196 Mar 06, 2019
Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
70710-1197 Mar 06, 2019
Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
70710-1198 Mar 06, 2019
Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
70771-1949 Mar 06, 2019
Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Lifesciences Limited
Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Lifesciences Limited
70771-1950 Mar 06, 2019
Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Lifesciences Limited
Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Lifesciences Limited
70771-1951 Mar 06, 2019
Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Lifesciences Limited
Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Lifesciences Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.